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PENCIRIAN FUNGSI PROTEIN MEMBRAN LUAR TolC Salmonella 
enterica subspecies enterica serovar Typhi DAN PERKAITANNYA 
DENGAN VIRULEN 
 
 
ABSTRAK 
 
Walaupun banyak kajian telah dijalankan ke atas Salmonella 
enterica subspesies enterica serovar Typhi (S. Typhi), agen penyebab 
demam kepialu manusia, hanya beberapa protein membran luarnya (OMPs) 
telah dicirikan secara berfungsi. Dalam kajian ini, mutan pelesapan tolC  
dihasilkan untuk mengkaji fungsi biologi TolC dalam strain S. Typhi yang 
telah diasingkan daripada pesakit demam kepialu akut. Pelesapan TolC 
menyebabkan peningkatan kerentanan kepada pelbagai cabaran 
antimikrobial, integriti membran dikompromi, dan pengurangan aktiviti 
pengeluaran efluks S. Typhi. Di samping itu, mutan Δ tolC mempunyai 
lekatan dan serangan yang lebih rendah dalam model in vitro jangkitan 
kultur sel manusia. Untuk pengesahan lanjut pelemahan ini, analisis PCR 
transkripsi berbalik (RT-PCR) menunjukkan pengurangan transkripsi gen 
bakteria yang berkaitan dengan serangan Salmonella. Susulan daripada itu, 
mutan tolC kurang dapat menyerang sel-sel HT-29 dan THP-1 berbanding 
strain asal dalam ujian serangan. Tambahan pula, analisis in vitro  
mendedahkan bahawa kehadiran mutant tolC intrasel adalah hipersitotoksik 
terhadap makrofaj manusia berbanding dengan strain liar, dan ia 
menyebabkan peningkatan transkripsi gen kemokin prokeradangan dalam 
makrofaj manusia. Secara keseluruhannya, data ini mencadangkan bahawa 
fungsi TolC diperlukan oleh S. Typhi untuk menghalang kematian sel 
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perumah dan melemahkan gerak balas imun perumah. Pelesapan tolC  
memberikan fenotip yang berbeza daripada strain asal liar. Ini 
menunjukkan bahawa fungsi TolC adalah berbeza daripada rakan 
proteinnya dalam efluks substrat  dan virulens. Kajian ini mencadangkan 
kemungkinan fungsi TolC dalam virulens dan kepatogenan S. Typhi. 
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FUNCTIONAL CHARACTERIZATION OF THE OUTER 
MEMBRANE PROTEIN TolC OF Salmonella enterica  subspecies  
enterica  serovar Typhi AND ITS ASSOCIATION WITH VIRULENCE 
 
 
ABSTRACT 
 
Although Salmonella enterica  subspecies enterica serovar Typhi (S. 
Typhi) has been well studied, only a few of its outer membrane proteins 
(OMPs) have been functionally characterized. In this study, a tolC  deletion 
mutant was generated to study the biological functions of TolC in S. Typhi 
strain that was isolated from an acute typhoid patient. Deletion of TolC 
caused increase susceptibility to a range of antimicrobials challenge, 
compromised membrane integrity, and reduced efflux activity of S. Typhi. 
In addition, the ΔtolC mutant was shown to have lower adhesion and 
invasion capability in an in vitro human cell culture infection model. 
Further confirmation of this attenuation  was investigated by the reverse 
transcription (RT)-PCR analysis which showed reduced transcription of 
bacterial genes related to the invasion of the Salmonella. Consequently, 
when invasion tests were performed with the tolC mutant, the tolC mutant 
was significantly less able to invade HT-29 and THP-1 cells than its 
parental strain. Furthermore, the in vitro analysis revealed that the 
intracellular presence of the tolC  mutant was hyper cytotoxic to human 
macrophages as compared to the wild-type strain, and it elicited the 
increased transcription of proinflammatory chemokine genes in human 
macrophages. Collectively, these data suggest that TolC function is 
required for S. Typhi to inhibit host cell death and dampen host immune 
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responses. Deletion of the tolC conferred a distinct phenotype from the 
wild-type parent strain. This indicates that the function of TolC is distinct 
from its protein partners in both effluxes of substrates and in virulence. 
This study suggests the possible functions of TolC in the virulence and 
pathogenicity of S. Typhi. 
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INTRODUCTION 
1.1 General introduction  
Typhoid fever continues to be a major cause of morbidity and mortality 
worldwide.  Salmonella enterica  subspecies enterica serovar Typhi (S. 
Typhi) causes typhoid fever in the human host. Typhoid fever can be 
described as a normalized acute infection of an organ like intestinal 
lymphoid tissue, reticuloendothelial system, and gallbladder. Buckle et al. 
(2012) had proposed that typhoid fever prevalence could be as high as 26.9 
million with 269,000 deaths. Most of cases were reported in young children 
(2008, Wain et al., 2015). The disease is limited to humans, but human 
chronic carriers act as reservoirs for the S. Typhi for further spread of the 
infection (Gunn et al., 2014). These claims may be due to S. Typhi ability 
to transmit its virulence from human-to-human. Their persistence alone 
makes the strains responsible for many cases worldwide. Several strategies 
are used by this pathogen to influence its virulence efficiency in its human 
host. These strategies include tolerating antimicrobial factors of the host 
and secreting a toxin that causes damage to the host cells. However, 
virulence and persistency are difficult to explain because these pathogenic 
bacteria have evolved various escape mechanisms and strategies for 
surviving in the human host even though one of the important mechanisms 
involve its efflux pump system. In Gram-negative bacterial pathogens, 
TolC is an outer membrane efflux pump protein that facilitates efflux 
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function and contributes to virulence and pathogenesis. Previous reports 
have reported that TolC-facilitated efflux functions have links to virulence 
and pathogenesis in several Gram-negative pathogens (Piddock, 2006b). 
The expression of efflux pumps appears to go along with the infection 
process of Gram-negative pathogens (Fernando and Kumar, 2013). 
According to these reports, question is rise that there is a link among the 
function of outer membrane efflux pump protein (TolC), and its 
involvement in the virulence of S. Typhi and various infection processes 
(such as colonization, and resistance from host defense). Thus, TolC 
potentially plays an important role in virulence; therefore, this study pays 
attention to the involvement of the TolC, outer membrane channel protein, 
in the virulence of S. Typhi in the human host.  
1.2 Problem statement and rationale of the study 
Outer membrane efflux pump proteins (OMPs) have essential functions 
in the physiology of bacteria,  for example,  adhesion and invasion of the 
host  cell , resistance to host serum, maintenance of the membrane 
integrity,  and passive and active transfer of substances (Tokuda, 2009). 
The most common OMPs, like TolC has been examined as a 
multifunctional protein because  of its contributions to maintenance of 
cell membrane integrity,  tolerance to acidic condition, elimination of 
metabolites, exportation of siderophores which are crucial in acquiring 
iron from surrounding environments, toxins exportation which encoded 
by plasmid and chromosomally,  for example,  hemolysin, colicin V, 
microcins, and virulence in host, as evident from studies in many Gram -
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negative pathogens, such as Enterobacter ,  Borrelia ,  Salmonella ,  Vibrio ,  
Legionella, Francisella ,  and Escherichia coli  (Wandersman and 
Delepelaire, 1990, Hwang et al . ,  1997, Delgado et al . ,  1999, Gil et al . ,  
2006, Bunikis et al . ,  2008, Ferhat et al . ,  2009a, Horiyama et al . ,  2010, 
Lee et al . ,  2014, Matsuo et al . ,  2013). TolC in E. coli ,  is promiscuous 
mainly because it  facilitates the use of multidrug r esistance efflux 
pumps of different famil ies (Lomovskaya and Lewis,  1992, Fralick, 
1996, Kobayashi et al. ,  2001, Nishino and Yamaguchi,  2001, Nishino 
and Yamaguchi, 2002, Kobayashi et al .,  2003b, Nishino et al .,  2003) . 
The biological functions of the TolC homologs in several Gram-
negative bacteria have already been widely explained in several  
published reports as mention , but the function of TolC in S .  Typhi is  
currently not well  understood . Hence, this study aims to investigate the 
function of TolC in the virulence of S .  Typhi.  
1.3 Objectives 
General objective:  
To study the role of TolC in the early steps of host cell invasion and TolC-
dependent hypercytotoxic and proinflammatory responses from host cells  
by using an in vitro system.  
Specific objectives  
• To construct a tolC deletion mutant and its 
complementation strain. 
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• To establish phenotypic characterization of S. Typhi tolC  
mutant.  
• To investigate the effect of tolC deletion on early steps of 
S. Typhi invasion in a host cell. 
• To observe the effect of tolC  deletion on hypercytotoxic 
and proinflammatory responses from host cells.  
• To determine whether a virulence-related factor, exported 
by TolC of S. Typhi, can restore the invasiveness of the 
tolC mutant.  
1.4 Overview of the study  
The hypothesis is that the gene locus tolC is involved in the virulence of 
S. Typhi to infect  human epithelial and macrophage cells to cause systemic 
infection, and it also has functions in the physiology of S. Typhi. To test 
this hypothesis, several goals have been set. First, a tolC deletion mutant 
of S. Typhi was constructed. After, the effects of the tolC  deletion were 
observed on the physiology of S. Typhi, such as antibiotic and detergent 
resistance ability, efflux function, growth curve, and maintenance of 
bacterial membrane integrity. Thereafter, the effects of tolC deletion were 
verified in S. Typhi with respect to its adhesion and invasion ability to host 
cell, and expression of its invasion-related genes. Subsequently, the effects 
of tolC deletion were observed on the proinflamantry response of host 
during infection of S. Typhi. Finally, it was determined whether a 
virulence-related factor, exported by TolC of S. Typhi, can restore the 
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invasiveness of the tolC mutant. The overview of the study is shown in 
Figure 1.1. 
  
        
Figure 1.1: Overview of Study 
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LITERATURE REVIEW 
2.1 Typhoid fever 
Typhoid fever is a severe systemic illness that affects the gallbladder and 
reticuloendothelial system of  the human body, and it causes prolonged 
fever, hepatomegaly, splenomegaly, stomach pain, anxiety, headache, and 
constipation. According to Hornick et al. (1970), this illness arises due to  
consumption of meals or drinking water which is  infected with 103-106 
CFU/mL of S. Typhi. With regards to persistence within the host , S. Typhi 
has extraordinary features that have not been completely demonstrated yet 
(Merrell and Falkow, 2004). After intake, S. Typhi pass through the gastric 
acid-abundant stomach and arrives at the intestine, where it  colonizes in 
the intestine. The pathogen adheres and invades the epithelial cells of the 
small intestinal tract; following which, they are phagocytosed by 
macrophages. This course of action requires a couple of type III secretion 
systems (T3SS), T3SS-1 and T3SS-2, which usually stimulated when S. 
Typhi get across epithelial cells of the intestine and survive within 
macrophages of the host respectively (Tischler and McKinney, 2010). 
Within the macrophages, the bacteria have the ability to survive in the 
phago-lysosome system and take benefit of free passage to the lymphatic 
and reticuloendothelial systems in the small intestinal tract, liver as well 
as spleen, and remain there for few days prior to being transferred back 
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towards the bloodstream (Everest et al., 2001, House et al ., 2001, Parry et 
al., 2002), as shown in Figure 2.1. 
 
Figure 2.1: Typhoid fever pathogenesis explaining the developmental 
phases of the illness. Each phase is labeled in numbers . Figure adapted 
from Tischler and McKinney, (2010). 
 
In recent years, fatalities of the disease have decreased, but the numbers of 
cases have increased. This observation is mainly due to  the use of 
antibiotics particularly fluoroquinolones (ciprofloxacin, nalidixic acid), 
cephalosporins (Ceftriaxone, Cefalexin), and macrolides (azithromycin) 
that are being used in the treatment of Typhoid fever (Zaki and Karande, 
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2011). These antibiotics help to reduce the number of deaths during typhoid 
fever, but also lead to the development of strains which are resistant to 
multiple drugs (Zaki and Karande, 2011). The increasing number of S. 
Typhi strains that are resistant to antibiotics remain a serious problem in 
endemic regions because these strains contribute to increase numbers of 
typhoid fever cases and complications in the treatment of the disease (Zaki 
and Karande, 2011). Currently, two vaccines are available to prevent S. 
Typhi infection: the first type is the polysaccharide capsule and Vi antigens 
that are administered through parenteral route, and the second type is  a live 
attenuated Ty21a strain that is given via oral route (Paterson and Maskell, 
2010, Martin, 2012). Their effectiveness is about 70 %, and both types do 
not provide long-term protection (Paterson and Maskell, 2010, Martin, 
2012). In view of this, new generation vaccines are being developed to 
improve efficiency and a long-term protection (Paterson and Maskell, 
2010, Martin, 2012, Tennant and Levine, 2015).  
2.2 Epidemiology of typhoid fever  
2.2.1 History of typhoid fever 
A French physician, Pierre Charles Alexandre Louis (1787 -1872) initially 
used the title ― typhoid fever  in the year 1829. William Budd (1811-1880) 
concluded in 1873 the fact that fecal–oral path is responsible for spreading 
of typhoid fever. In the year 1880, Karl Eberth (1835-1926) noticed rod-
shaped microorganisms within the lymph nodes and spleens of individuals 
suffering from typhoid fever, and he found the causative agent Salmonella 
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Typhi (S. Typhi). In the same way, Lignieres credited the term Salmonella; 
successively in 1885, Daniel Elmer Salmon recognized Salmonella 
Choleraesuis from pigs. In the year 1884, Georg Gaffky (1850-1918) 
cultured S. Typhi from affected individuals. In the 1940s, Fritz Kauffmann 
(1899-1978) stretches the research of Phillip Bruce White (White, 1926), 
and he set up a serological distinction of Salmonella . By using 
chloromycetin (chloramphenicol), Theodore E. Woodward (1914-2005) 
and colleagues effectively cured typhoid affected individuals in 1948 
(Woodward et al ., 1948, Woodward et al., 1950). 
2.2.2 Carriers of S. Typhi 
The colonization of S. Typhi in humans mainly causes serious symptoms, 
but sometimes the infection is not associated with any symptom s (Parry et 
al., 2002). Typically, 1-5 % typhoid fever patients become chronic carriers 
of S. Typhi (Parry et al., 2002). In asymptomatic carriers, bacteria usually 
persist in the gallbladder in the form of biofilms that protect s them against 
the antibiotics and effectors of the host’s immune system (Sinnott and 
Teall, 1987, Tabak et al., 2009, Crawford et al., 2010, Hoiby et al., 2010, 
Gonzalez-Escobedo et al., 2011, Basnyat and Baker, 2015). These 
asymptomatic typhoid carriers excrete bacteria in  their stool, which 
increases the risk of infection in the population that is a major threat to 
public health (Parry et al., 2002, Bhan et al ., 2005).  
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2.2.3 Distribution and infectivity of S. Typhi 
The spread of typhoid fever is worldwide, however, it much more 
widespread in Oceania, The African continent, Latin America as well as 
Asia with an occurrence rate of cases 15.4, 49.8, 53.1, and 274.3 for each 
100,000-human population respectively (Crump et al., 2004).  
In the year 2000, the prevalence rate of typhoid fever was highest in Asia, 
and with more than 100 cases per 100,000 populations , particularly in 
Southeastern and South-central part of Asia, including Bangladesh, India, 
Malaysia, and Pakistan (Crump et al., 2004) because this serovar is mainly 
found in developing countries  (Rhen et al., 2007), as shown in Figure 2.2. 
The World Health Organization (WHO, 2008) reports that typhoid fever 
approximates 16.6 million infections with an average of 600,000 deaths 
worldwide each year. A report in 2010 indicated that typhoid fever cause 
approximately 21.7 million infections and 217,000 deaths annually (Crump 
and Mintz, 2010). A separate report in 2012 indicated that typhoid fever 
incidence could be as high as 26.9 million  infections with 269,000 deaths 
as proposed by Buckle et al. (2012). The complications of the disease that 
are related to the human-adapted bacterial pathogen in endemic regions of 
the world have been reported by Wain et al. (2015). Studies claim that 
typhoid incidents are greater than 70 % in developed nations tend to come 
from individuals who have experienced travel to a typhoid endemic region 
(Mead et al., 1999, Ackers et al., 2000, Reller et al ., 2003, Connor and 
Schwartz, 2005, Ekdahl et al., 2005, Lynch et al., 2009). Since the source 
was mainly from travelers who returned from their journey, in 100,000 
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passengers, there are 3 to 30 cases of typhoid fever (Steinberg et al., 2004). 
However, outbreaks can happen, through imported fruits contaminated with 
the pathogens (Katz et al., 2002), or via meal services employees  who are 
asymptomatic carriers of the S. Typhi (Greig et al., 2007). The dropped 
numbers of typhoid fever cases observed in the developed world in the 
1940s were result of improved sanitation, disposal of waste materials, food 
handling, personalized cleanliness, unpolluted drinking water and the use 
of antibiotics to treat the disease (Mølbak et al ., 2006, WHO, 2008). 
However, in 2013, in the United States, 400 cases are reported, and the 
disease is estimated to occur in about 5 ,700 people per year (CDC, 2014, 
Jackson et al., 2015). 
 
Figure 2.2: The global burden of typhoid fever. Figure adapted from 
Crump et al (2004). 
 
As typhoid fever is associated with poor hygiene and lack of health 
facilities; therefore, the disease mostly occurs in underdeveloped countries 
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(Rhen et al., 2007). In endemic areas, the bacterium spread through 
contaminated water and food (Nguyen et al., 2009). The fecal-oral spread 
of the bacteria is a major problem because contamination is produced by 
asymptomatic carriers and patients who release pathogen in their feces 
(Basnyat, 2007). 
The disease evidently occurs mostly in 1 - 19 year-aged (Lin et al., 2000, 
Merrell and Falkow, 2004). On the other hand, more recent information 
revealed that typhoid infection rate is 44 – 54 % in children under 5 years 
old (Graham, 2002, Siddiqui et al., 2006, Ja’afar et al ., 2013). 
Fluoroquinolones work well (Parry et al., 2002), but resistance to these 
types of drugs are increasing and results in increasing numbers of 
resistance strains (Threlfall, 2002). S. Typhi that resistance to 
chloramphenicol is mediated by plasmid gene while nalidixic acid 
resistance is mediated by chromosomal gene (Ray et al ., 2006). The risk of 
death may be as high as 25 % without treatment, while with t reatment it is 
between 1- 4 % (Wain et al., 2015, 2008). 
Generally, disease spread is an important characteristic for the 
complication of the disease (Rhen et al., 2007). This serovar infects only 
humans and does not colonize in animals, so it 's only involved in human to 
human transmission (Rhen et al ., 2007). This lack of zoonosis is a great 
benefit to humans. This strict adaptation to the human host ; consequently, 
strictly limits the study of this bacteria because there is no animal model 
that can reproduce systemic illness caused by S. Typhi. Existing knowledge 
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about the virulence of this serovar comes largely from studies with S. 
Typhimurium in mice (Haraga et al., 2008). The genomes of the two 
serovars S. Typhi and S. Typhimurium have more than 90 % homology 
(Vidal et al., 1995, Alemán et al., 2009). Thereby S. Typhimurium has long 
been used to reproduce a systemic infection in a mouse model having a 
mutation in the Nramp1 protein, making it very susceptible to mice (Vidal 
et al., 1995), so the pathogenesis of S Typhi has been elucidated in large 
part through this mouse model. However, the interaction between the 
pathogen and its own host is critical to understand ing pathogenesis by use 
of mouse model. Therefore, research is still dedicated to finding an 
appropriate model to conduct in vivo  infections (Daigle et al ., 2001a). 
However, sequencing of the complete genome of S. Typhi CT18 was 
completed in 2011, and it is available on the website 
(http://www.sanger.ac.uk/Projetcs/S_Typhi/ ) since this comprehension has 
been useful to the advancement of research on this pathogen.   
2.2.3 (a) Typhoid fever in Malaysia 
In Malaysia, all classes of the community are affected by typhoid fever 
(Malik and Malik, 2001). Additionally, some other risk factors have been 
identified, for example, interaction with the infected individual, inadequate 
domestic cleaning, cleaning hands without utilizing soap, and earlier 
infection with Helicobacter pylori (Bhan et al., 2005). In endemic areas, 
the youngest age group of 1-19 years have the highest prevalence of 
typhoid fever (Lin et al., 2000, Ja’afar et al., 2013). Choo et al. (1988) 
have described that 7.3 years is the average age of typhoid fever patients 
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who admitted to Hospital Universiti Sains Malaysia. Typhoid cases in 
Malaysia between 1978 to 1990 occurred yearly with an occurrence rate of 
10.2-17.9 incidents per 100,000 human population with a higher as 50.3 
incidents per 100,000 population in the state of Kelantan (Yap and 
Puthucheary, 1998). However, a significant progress was accomplished in 
decreasing the incidence of typhoid fever in Kelantan from 14.7 incidents 
per 100,000 human population in 2000 to 2.8 incidents per 100,000 human 
population in 2010. According to a recent report by the Ministry of Health, 
Malaysia was categorized as a low endemic area for typhoid fever with a 
yearly prevalence rate less than 10 cases per 100,000 populations from the 
year 1995 to 2014 (Figure 2.3). Kelantan state of Malaysia has the 
maximum prevalence rate (10-100 case/ 100,000) of typhoid fever and 
categorized as an average endemic region (Shah SA et al., 2012). In the 
year 2001, typhoid cases in Kelantan were 37 per 100,000 (Wan Mansor et 
al., 2011), which dropped to 24.4 per 100,000 in 2003, 10 per 100,000 in 
2008, 3.29 per 100,000 in 2009, and 2.8 per 100,000 in the year 2010 
(Figure 2.4). This was credited to the establishment of appropriate 
observing and surveillance systems by the Public Health Department of 
Kelantan State (Wan Mansor et al., 2011), as presented in Figure 2.4. An 
outbreak of typhoid fever happened in the year 2005 with a major flood in 
the state because the wells were polluted with sewage overflow, and water 
sources were contaminated in rural areas (Shah SA et al., 2012). 
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Figure 2.3: Occurrence of typhoid fever in Malaysia from the year 1995  
till 2014. (Data from Ministry of Health, Malaysia, 2015). 
 
 
 
 
Figure 2.4: Pattern of typhoid fever in Kelantan state from the year 1994 
till 2014. (Data from Kelantan State Public Health Department, 2015).  
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2.3 Molecular basis of systemic infection  
2.3.1 Adhesion and invasion  
The S. Typhi bacterium adhere to the epithelial cells of the host intestine, 
and this adhesion is the primary mechanism of action towards the 
establishment of the infection. Different events may happen during this 
period like the tissue invasion at the time of colonization (Rhen et al., 
2007). S. Typhi has interactions with the M cells of Peyer's patches of  the 
intestinal tract. This entrance makes possible for bacteria to get across the 
epithelial hindrance through pinocytosis which is the same as phagocytosis 
(Kaufmann SH et al., 2001). However, in this interaction, M cells also 
make it possible for bacteria to get transported towards the lymphoid T 
cells (Haraga et al., 2008). A few studies support the idea that the bacteria  
could possibly be phagocytosed by CD-18 positive cells (Wilson et al., 
2008), such as monocytes, macrophages, dendritic cells, and neutrophils.  
These immune cells engulf Salmonella and transport them to various 
systemic sites through the blood and lymph (Haraga et al., 2008). Unlike 
entry through M cells, this transportation pathway permits S. Typhi to 
evade the immune system. Thus, the bacteria are able to spread without 
inducing a significant inflammatory response in the host.  
S. Typhi can also invade epithelial cells of the intestine by injecting 
effectors into the host cell through utilization of its specific T3SS-1-type 
secretion system and interact with actin cytoskeleton of the epithelial cell 
(Haraga et al ., 2008). The effector proteins that are essential to manipulate 
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the cytoskeleton of the host cell for invasion, include, SopE, SopE2, SopB, 
SipB, SipA, and SipC; thus, the membrane of the epithelial cell can be 
corrugated and allows the bacterium to internalize into  the host cell. These 
entry strategies permit S. Typhi to adhere and invade epithelial cells of the 
gut and to arrive in the lamina propria. This passage via the hindrance of 
the epithelium is an important stage to infection because S. Typhi needs to 
pass within the body of the host to produce a systemic disease. However, 
S. Typhi can evade the immune system that produce inflammatory response 
that might be able to eliminate it.  
 
 
Figure 2.5: Mechanisms used by Salmonella to cross the cell barrier 
bowel. 
1) Salmonella is internalized into cells by pinocytosis and is  taken by 
macrophages to the underlying epithelium. 2)  Salmonella  adheres to 
epithelial cells and using its T3SS-1 to secrete effector into the cytoplasm 
of cells and causes remodeling of actin. 3) Dendritic cells located on the 
basolateral side can capture the bacteria present on the apical side by 
extending pseudopodia. Figure adapted from Sansonetti (2004). 
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2.3.2 Evasion of the immune system 
S. Typhi has the potential to infect epithelial cells without initiating any 
noticeable inflammatory reaction. When invasion happens through M cells 
of Peyer's patches or by endocytosis , this requires the LPS and flagellin 
that are very antigenic (Wilson et al., 2008). The capsule upregulation 
during access into epithelial cells  which hides LPS and flagellin of S. 
Typhi, and allows it to evade being detect ion by the Toll-like receptor 
(TLR) - 4 and 5 (Wilson et al ., 2008). In this condition, the infected 
epithelial cell will not produce IL-8 which is responsible for activation of 
a localized inflammatory reaction at this stage of the infection , so the 
patient infected with S. Typhi does not suffer from diarrhea at this stage; 
subsequently, this allows S. Typhi to cause a systemic infection (Wilson et 
al., 2008). However, S. Typhimurium infection in humans is associated 
with a strong inflammatory response in the gut (Santos et al., 2009) because 
this response is due to the recognition of several components that are found 
on the surface of the bacteria by the immune system of the host (Wangdi 
et al., 2012). Among others, flagellin, the major component of flagella is 
recognized by TLR-5 and IPAF (IL-1β converting enzyme protease 
activating factor), which causes the release of interleukin-8 (IL-8) by the 
enterocytes, and IL-18 and IL-1β by macrophages (Santos et al., 2009, 
Wangdi et al., 2012). LPS is recognized by the TLR-4 while T3SS-1 by 
NLRC4 (nucleotide-binding oligomerization domain-like receptor family 
caspase-associated recruitment domain-containing protein 4) (Santos et al., 
2009, Wangdi et al., 2012). These interactions trigger characterized 
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inflammatory responses that recruit neutrophils at the infection site 
because the action of neutrophils causes damage to the intes tinal 
epithelium and extravascular leakage of fluids in the intestine, thus 
contributing to diarrhea (Santos et al., 2009).  
2.3.3 Survival and systemic infection 
Bacteria grow and increase its number inside the macrophages. As stated 
previously, S. Typhi is a facultative intracellular bacterium. Which means , 
this is their benefit of getting engulfed by macrophages and resides in 
macrophages. To avoid digestion through phagocytic cells, intracellular 
bacteria can multiply in these cells. The absence of phagolysosome 
formation is an essential function of the virulence of Salmonella, which 
prevents digestion by macrophages (Haraga et al., 2008). The degree of 
interaction among S. Typhi and the phagocytic cell is essential for the 
progression of the disease, in which the bacteria transform the vacuole by 
utilizing effectors, such as SipA, SopB, SopD, and SopE2, which modify 
macrophage cell signaling and turns into a niche regarding survival and 
replication of intracellular bacteria (Haraga et al., 2008). S. Typhi has the 
ability to modify most crucial components of the host protection 
mechanism against intracellular pathogens (Daigle et al., 2001b).  
Survival in macrophages has been demonstrated for S. Typhimurium in 
murine models of typhoid fever. In fact, S. Typhimurium mutant’s 
defective in SPI-2 is severely attenuated in the mouse infection,  and being 
incapable of proliferating in various organs (Hensel, 2000). The SPI-2 is 
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also essential for the survival and intracellular proliferation of S. 
Typhimurium in murine macrophages during in vitro infection (Hensel et 
al., 1998). However, the intracellular survival of S. Typhi in human 
macrophages appears to be independent of the SPI-2, suggesting that the 
SST3-2 is not obligatory for survival and intracellular growth of S. Typhi 
(Forest et al., 2010). Salmonella  also has an important defense system to 
protect from antimicrobial factors in macrophage, for example, efflux 
pump (Fernando and Kumar, 2013). Survival in macrophages is essential 
for the establishment of systemic infection, and this allows passage of S. 
Typhi to the lymph nodes, liver, and spleen of the host (Fields et al., 1986, 
Dragunsky et al., 1990, Vazquez-Torres et al., 1999, House et al ., 2001).  
One to two weeks after intake of the bacterium, many bacteria are released 
into the bloodstream and infect  the liver, gall bladder spleen, bone marrow, 
and Peyer's patches of the host (Parry et al., 2002). At this stage of 
infection, the symptoms of typhoid fever appear  include, high fever, 
lethargy, headaches, and stomach pain (House et al ., 2001). The bacteria 
associated with the gallbladder are excreted in the feces and can reinfect 
the intestine, which can lead to severe infections ; at this point, there is  a 
perforation, intestinal bleeding, encephalopathy, and possibly death 
(House et al., 2001). During its cycle of infection, Salmonella  encounters 
various environmental changes, and its ability to adapt quickly to changes 
in environmental conditions is essential for survival and virulence of 
Salmonella . In response to various environmental signals, Salmonella  
expresses several genes that are related to stress tolerance and virulence 
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factor that are required to meet these changing conditions. Like most 
bacteria, Salmonella has multiple control systems to encounter the 
different stress conditions. Among the main regulatory systems are marA, 
soxS or rob that are usually increase resistance to several antibiotics, and 
PhoPQ, BaeSR, and EvgAS regulons that are responsible for resistance 
against superoxides, endurance under acidic milieus in host, and tolerance 
of extracytoplasmic stress during infections (Aono et al., 1998, Eguchi et 
al., 2003, Nishino et al., 2005, Zhang et al ., 2008). 
2.4 Taxonomy and nomenclature of S. Typhi 
The genus Salmonella consists of two species, S. enterica and S. bongori , 
and S. bongori is also referred to as subspecies V. These species are further 
divided into six subspecies (Figure 2.6), which are biochemically 
distinguished into serovars based on their carbohydrate, flagellar, and 
lipopolysaccharide (LPS) structures. An antigenic formula that depends on 
somatic (O) and flagellar (H) antigens , in addition to capsular (Vi) 
antigens, are used to describe all Salmonella  serotypes (Fierer and Guiney, 
2001). 
S. Typhi is a highly conserved serovar within subspecies I of the S. enterica 
(Tang et al., 2013). The Kaufmann-White scheme classifies S. Typhi as 
Group D with O-antigen type O9-12, phase1 flagellin type H: d, and Vi 
capsule positive. Therefore, S. Typhi is normally monophasic. Most S. 
Typhi falls within the Kaufmann-White classification, but rare isolates are 
Vi-negative (Dougan and Baker, 2014).  
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Figure 2.6: Classification of Salmonella species and subspecies.  
Figure adapted from Hurley et al. (2014). 
 
2.5 Characteristics of S. Typhi  
Salmonella is categorized as Gram-negative, straight rod-shaped, 
nonencapsulated, non-spore forming, facultative, and usually motile with 
peritrichous flagella (Gray and Fedorka-Cray, 2002, Mølbak et al., 2006) 
(Figure 2.7). The bacterium has a length of 2.0 to 5.0 μm , and a thickness 
of 0.7 to 1.5 μm  (Holt et al., 1994). The ideal temperature range within 35 
to 40°C is appropriate for growth of Salmonella (Dickson, 2000) although 
it can survive through a broad range of temperatures from 8 to 45°C (Hanes, 
2003). A pH range of 4.5 to 9.0 has determined to be optional for the growth 
of Salmonella (D'Aoust, 1989). On the other hand, pH range within 6.5 to 
7.5 is most favorable for growth (Garcia-Del Portillo, 1999). In addition, 
the pathogen S. Typhi can survive more than a few months in water and 
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soil (Tran et al., 2005). Salmonella is often aerogenic - generating gas from 
glucose, and can make use of citrate as an only carbon source. It is unable 
to ferment lactose, but it is competence to generate hydrogen sulfide (H2S) 
gas from Sulphur-containing amino acids, so these features are utilize to 
recognize colonies on culture media (Ryan and Falkow, 1994). 
The outer membrane of Salmonella accounts for around 60 % of the protein 
that is present in the whole cell envelope as well as around 90 % of the 
entire lipoprotein (Ohl and Miller, 2001). The outer membrane lipoproteins 
are usually attached to the membrane in a similar way as those located on 
the inner membrane, but these are situated on the inner instead of  the outer 
leaflet of the membrane layer  (Ohl and Miller, 2001). The integral proteins 
of the outer membrane are completely different from their inner membrane 
counterparts because they fold to create β -barrel conformations which span 
the membrane and work as channels that allow the influx of nutrients, 
exportation of waste materials, and efflux pump for amphipathic molecules 
which are unable to export from the membrane by any other means 
(Nikaido, 2003, Doerrler, 2006, Ruiz et al., 2006, Rigel and Silhavy, 2012). 
Although S. Typhi has developed various mechanisms for survival in the 
host and resistance against antibacterial agents, efflux function is an 
important mechanism that causes multiple drug resistant phenotype and 
complication in disease. The efflux pumps are present in the cell membrane 
of the bacteria because they are involved in the mechanism that pumps out 
any toxic substance from bacterial cells.  
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Figure 2.7: Structure of Salmonella Typhi.  
(Figure adapted and modified from from University of 
British.Columbia.http://wiki.ubc.ca/File:Salmonella_virulence_factors
1.j). 
Multidrug efflux pumps of Salmonella  cause an obstruction to the treatment 
of disease because the efflux pumps facilitate the removal of structurally 
different substrates from the bacterial cell and giving an effective 
protection against antimicrobials (Nishino et al., 2009). The efflux pumps 
Efflux pump 
